| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 3e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |